Atar Application: Industrial

Atar

Uncontrolled Hypertension needs a
dependable antihypertensive

Earlier known as Atorden Tablets

Competent HMG-CoA reductase inhibitor
significantly reduces LDL, VLDL & triglycerides & raises HDL

• 71% of the patients reached the NCEP
  goal at the starting dose
• Significant reduction in LDL
  cholesterol with in first 2 weeks
• Avert Study effective alternative to
  angioplasty
• Miracle study Reduces recurrent
  ischemic events in patients of acute coronary syndrome

Ideal single drug therapy in

• Hypercholesterolemia
• Diabetic dyslipidemia
• Combined hyperlipidemia